Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

Camargo JF, Quinones MP, Mummidi S, Srinivas S, Gaitan AA, Begum K, Jimenez F, VanCompernolle S, Unutmaz D, Ahuja SS, Ahuja SK.

J Immunol. 2009 Jan 1;182(1):171-82.

2.

PKCtheta and PKA are antagonistic partners in the NF-AT transactivation pathway of primary mouse CD3+ T lymphocytes.

Hermann-Kleiter N, Thuille N, Pfeifhofer C, Gruber T, Schäfer M, Zitt C, Hatzelmann A, Schudt C, Leitges M, Baier G.

Blood. 2006 Jun 15;107(12):4841-8. Epub 2006 Mar 2.

3.
4.

Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.

Lee MJ, Woo MY, Chwae YJ, Kwon MH, Kim K, Park S.

Immunobiology. 2012 Oct;217(10):986-95. doi: 10.1016/j.imbio.2012.01.012. Epub 2012 Jan 16.

PMID:
22445722
5.

6-Methoxyflavone inhibits NFAT translocation into the nucleus and suppresses T cell activation.

So JS, Kim GC, Song M, Lee CG, Park E, Kim HJ, Kim YS, Jun CD, Im SH.

J Immunol. 2014 Sep 15;193(6):2772-83. doi: 10.4049/jimmunol.1400285. Epub 2014 Aug 11.

6.

Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.

Sullivan NL, Eickhoff CS, Zhang X, Giddings OK, Lane TE, Hoft DF.

J Immunol. 2011 Aug 1;187(3):1358-68. doi: 10.4049/jimmunol.1100033. Epub 2011 Jun 29.

7.

A mandatory role for STAT4 in IL-12 induction of mouse T cell CCR5.

Iwasaki M, Mukai T, Nakajima C, Yang YF, Gao P, Yamaguchi N, Tomura M, Fujiwara H, Hamaoka T.

J Immunol. 2001 Dec 15;167(12):6877-83.

8.

miR-9 enhances the transactivation of nuclear factor of activated T cells by targeting KPNB1 and DYRK1B.

Zeng Y, Wang Y, Wu Z, Kang K, Peng X, Peng W, Qu J, Liu L, Raj JU, Gou D.

Am J Physiol Cell Physiol. 2015 May 1;308(9):C720-8. doi: 10.1152/ajpcell.00299.2014. Epub 2015 Feb 18.

9.

IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.

Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M.

Exp Hematol. 2008 Feb;36(2):181-92. Epub 2007 Nov 26.

PMID:
18023521
10.

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.

Lozano T, Villanueva L, Durántez M, Gorraiz M, Ruiz M, Belsúe V, Riezu-Boj JI, Hervás-Stubbs S, Oyarzábal J, Bandukwala H, Lourenço AR, Coffer PJ, Sarobe P, Prieto J, Casares N, Lasarte JJ.

J Immunol. 2015 Oct 1;195(7):3180-9. doi: 10.4049/jimmunol.1402997. Epub 2015 Aug 31.

12.

Suppression of nuclear translocation of nuclear factor-kappaB and nuclear factor of activated T cells by Younggaechulgam-tang.

Shin HY, Song YS, Hwang CY, Shin TY, Kim HM.

Immunopharmacol Immunotoxicol. 2004;26(4):545-58.

PMID:
15658604
13.

The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines.

Tsatsanis C, Patriotis C, Bear SE, Tsichlis PN.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3827-32.

14.

Filamin A is required for T cell activation mediated by protein kinase C-theta.

Hayashi K, Altman A.

J Immunol. 2006 Aug 1;177(3):1721-8.

15.
16.

IL-12 plays a pivotal role in LFA-1-mediated T cell adhesiveness by up-regulation of CCR5 expression.

Mukai T, Iwasaki M, Gao P, Tomura M, Yashiro-Ohtani Y, Ono S, Murai M, Matsushima K, Kurimoto M, Kogo M, Matsuya T, Fujiwara H, Hamaoka T.

J Leukoc Biol. 2001 Sep;70(3):422-30.

PMID:
11527992
17.
18.

Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5.

Lynch EA, Heijens CA, Horst NF, Center DM, Cruikshank WW.

J Immunol. 2003 Nov 15;171(10):4965-8.

19.

Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.

Martínez-Martínez S, Gómez del Arco P, Armesilla AL, Aramburu J, Luo C, Rao A, Redondo JM.

Mol Cell Biol. 1997 Nov;17(11):6437-47.

20.

TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.

Lehnert C, Weiswange M, Jeremias I, Bayer C, Grunert M, Debatin KM, Strauss G.

J Immunol. 2014 Oct 15;193(8):4021-31. doi: 10.4049/jimmunol.1303242. Epub 2014 Sep 12.

Supplemental Content

Support Center